SmartLabs

SmartLabs is a company revolutionizing the construction and utilization of laboratory spaces in the biotechnology and life sciences industries. Founded in 2015, the company's innovative approach has attracted significant attention, with the latest $48.00M Series C investment on 18 January 2024 from notable investors including ArrowMark Partners, WINSLOW CAPITAL, and Conversion Ventures.

SmartLabs' mission is to accelerate the pace of scientific discovery by streamlining the process of building and utilizing lab spaces. By reducing the traditional 9 to 12-month construction timeline to a mere 4 weeks, the company enables member teams to commence their work sooner, ultimately leading to expedited results. Additionally, the company's proactive operational support and agility in adapting lab spaces to evolving scientific needs further enhances efficiency.

With locations in key innovation hubs such as MIT area of Cambridge, Innovation Square in the Boston Seaport, Boston Landing, and South San Francisco, SmartLabs is strategically positioned to cater to the dynamic needs of the scientific community. The company's commitment to empowering its members to shape the future underscores its dedication and impact in the biotechnology and life sciences sectors. Visit their website to request a tour and learn more about their groundbreaking approach.